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Announcement
ISLAR’98mlnternational Symposium on Labora-
tory Automation and Robotics
Preliminary programme
ISLAR’98, the sixteenth in a continuing series of Sym-
posia dedicated to laboratory automation and robotics,
will be held at the Boston Park Plaza Hotel from 18 to 21
October 1998. A strong emphasis will be placed on
presentations by senior laboratory managers on applica-
tions in drug discovery research, pharmaceutical and QC
analysis, bioanalytical techniques, and chemical analysis.
The three-day programme consists of over 100 podium
and poster presentations describing laboratory robotics
and laboratory workstation procedures from pharma-
ceutical, biotechnology and chemical laboratories. The
Symposium’s technical presentations and informal dis-
cussions provide an excellent opportunity for laboratory
managers, automation users and novices to exchange
ideas and applications experience. In addition, there
are six, free, laboratory-automation focused short courses
this year. 1998 session topics include:
combinatorial chemistry/process optimization
automated structural characterization
ultra-high throughput screening
data management/data handling
managing laboratory automation
chemical analysis
pioneer awardees: future trends in automation
automated compound distribution drug discovery
high throughput screening
methods transfer and validation
pharmaceutical analysis
advanced topics
bioanalytical assays
The opening session will feature three keynote speakers:
Integrating drug discovery technologies
ft. A. Bristol, Parke-Davis Pharmaceutical Research, Ann Arbor,
MI, USA
The pharmaceutical industry is entering a new era
wherein a number ofnew and enabling technologies such
as combinatorial chemistry, ultra-high throughput
screening, genomics, data management, etc. are matur-
ing simultaneously. In addition, new and improved
automation capabilities will have a dramatic impact on
the optimization of these new technologies. This combi-
nation has the potential to transform pharmaceutical
discovery into a highly efficient technologically advanced
process which will demand appropriate resourcing and
integration for optimal efficency.
As a Vice President at Parke-Davis, James A. Bristol is
responsible for the Departments of Chemistry, Discovery Infor-
matics and Compound Management.
Coordinated development of multi-site/multi-
functional analytical robotics applications: chal-
lenges and visions
E. F. McNiff, Bristol-Myers Squibb, Princeton, 2Vff, USA
The analytical development laboratory provides multiple
opportunities for increasing productivity through auto-
mation and robotics. A challenge exists in maintaining
the automation creativity of individual scientists while
providing a mechanism for an integrated and coordi-
nated approach within a multi-site, multi-functional
organization. A wide range of automated systems have
come from a diverse mix of scientists and engineers. An
overview of these systems will be provided with an
emphasis on the success and challenges of the various
development approaches which were utilized.
Edward F. McNiff is Vice President ofAnalytical Research and
Development where his primary responsibility is to provide
direction and coordination of all aspects of analytical chemistry
and analytical biochemistry.
Quality control: organization, cycle times, compli-
ance and efficiency
j. M. Hawkins, Janssen Pharmaceutica, Titusville, 2VJ, USA
Understanding the contributions that the laboratory can
make in product/process development, process improve-
ment, market surveillance, and general business is key to
the pharmaceutical business today. Poor laboratory
practice yields compliance issues, increased cost, in-
creased cycle time and delayed product introductions.
This talk will cover key areas of customer satisfaction, the
role of the quality control and quality assurance labora-
tories, measures of accountability and progress, and an
example of how laboratory robotics can help meet
important goals.
Currently Vice President of QA at Janssen Pharmaceutica,
Juanita M. Hawkins has 25 years experience in microbiology,
sterilization, quality assurance and operations.
For more information contact Christine O’SVeil, ISLAR, 68 Elm
Street, Hopkinton, MA 0178, USA. Tel.: O0 01 508 497 2224,
fax: O0 01 508 435 3439, e-mail: islar@islar.com, website:
www.islar.com
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